Jabez Biosciences, Inc. filed a Form D with the Securities and Exchange Commission on 2026-03-26.
Jabez Biosciences, Inc. filed a Form D notice of an exempt securities offering with the SEC on March 26, 2026. The filing reports $31K sold. Its industry group is Biotechnology. It names Tamara Jovonovich (Executive Officer, Director, Promoter), Brian Cogley (Executive Officer, Director), Robert Lewis (No family relationship with Martin Lewis or Michael Lewis) (SEC Form D, March 26, 2026).
125 companies raised this week.
Companies that just raised money, and the people to call. Before you unlock: the company, the amount, the date and what is inside (for example 2 people, phone, LinkedIn). After: the officers and directors the filing names with their roles, how to reach the company, and a person's email only when we found one.
| Andersen Aggregator LLC | $1.9B | Business services |
| AT Umbrella LLC | $1.9B | Business services |
| Legora, Inc. | $221M | AI and software |
| MD INVESTMENT LLC | $169M | Business services |
| Serval Inc. | $149M | AI and software |
Is this your company?
Sell to companies like Jabez Biosciences, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2026-03-26 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Jabez Biosciences, Inc.
Free to see. No signup.
More on the people and the money behind Jabez Biosciences, Inc., from the filings we hold.
Biotechnology raises by companies based in Pennsylvania, filed in March 2026, largest first.
Get an email when Jabez Biosciences, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Jabez Biosciences, Inc. raises, hires or launches. No email unless you switch it on.
Watch Jabez Biosciences, Inc. →Get the full cited report on Jabez Biosciences, Inc.
What the filing shows about Jabez Biosciences, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Jabez Biosciences, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Jabez Biosciences, Inc.'s address as 2009 Mackenzie, Suite 100, Cranberry Twp., PA 16066.
Saved here on this device in the meantime, so nothing is lost either way.
Full funding history for Jabez Biosciences, Inc. →
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Order the Full Report on Jabez Biosciences, Inc. See pricing
Jabez Biosciences, Inc. is a registered filer with the SEC (CIK 2038185) and has filed since 2025-10-21. 3 filings are on record, the latest on 2026-03-26.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Jabez Biosciences, Inc.'s Form D of 2026-03-26 names Tamara Jovonovich, Brian Cogley, Robert Lewis and 4 more as its officers, directors or promoters.
Its new offerings report $3.91M sold across 3 offerings, as its own filings state.
A hollow marker is an amendment (Form D/A); a solid one is an original Form D. The larger marker is the filing this page is about.
Trailing twelve months. 771 filings in Biotechnology, totalled by week. The dot is this raise, $31K, on the same scale — one filing against the whole group's total, so it sits low by construction.
Checked away from the filing. What is below does not come from the record on sec.gov.
The title and description the site itself served, answering 200, after redirecting from https://jabezbio.com. Not a cached copy and not the company's directory entry — what was live when we asked.
Tamara Jovonovich is named as Executive Officer and Director and Promoter on the Form D that Jabez Biosciences, Inc. filed with the SEC on 26 March 2026, one of 7 people that filing names.
Brian Cogley is named as Executive Officer and Director on the Form D that Jabez Biosciences, Inc. filed with the SEC on 26 March 2026, one of 7 people that filing names.
On the filing as: Executive Officer, Director, Promoter.
Robert Lewis is named as No family relationship with Martin Lewis or Michael Lewis on the Form D that Jabez Biosciences, Inc. filed with the SEC on 26 March 2026, one of 7 people that filing names.
Bruce Cassidy is named as Director on the Form D that Jabez Biosciences, Inc. filed with the SEC on 26 March 2026, one of 7 people that filing names.
On the filing as: Director.
Martin Lewis is named as No family relationship with Michael Lewis or Robert Lewis on the Form D that Jabez Biosciences, Inc. filed with the SEC on 26 March 2026, one of 7 people that filing names.
On the filing as: Promoter.
Michael Lewis is named as No family relationship with Martin Lewis or Robert Lewis on the Form D that Jabez Biosciences, Inc. filed with the SEC on 26 March 2026, one of 7 people that filing names.
David Mehalick is named as Promoter on the Form D that Jabez Biosciences, Inc. filed with the SEC on 26 March 2026, one of 7 people that filing names.
7 people named on the filing — 3 holding an executive role, 2 as directors only and 2 named in another capacity.
Named as of the 2026-03-26 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Jabez Biosciences, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Jabez Biosciences, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Jabez Biosciences, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Jabez Biosciences, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Jabez Biosciences, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov, and from the company's own site, read directly on 2026-09-26 (jabezbio.com).
Each opens in a new tab, filled in for Jabez Biosciences, Inc.. With no account yet, you sign up free and land on the result.
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/jabez-biosciences-inc-form-d-26000001